Global Human Tuberculosis Vaccine Market Research Report 2024(Status and Outlook)
Report Overview
This report provides a deep insight into the global Human Tuberculosis Vaccine market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Human Tuberculosis Vaccine Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Human Tuberculosis Vaccine market in any manner.
Global Human Tuberculosis Vaccine Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
GlaxoSmithKline
Merck
Serum Institute of India
Valneva
Archivel Farma
BIOFABRI (Zendal)
Japan BCG Laboratory
GreenSignal Bio Pharma
AJ Vaccines
Taj Pharma India
Biomed Lublin
Market Segmentation (by Type)
Intradermal
Percutaneous
Market Segmentation (by Application)
Pediatrics
Adults
Geographic Segmentation
%li%North America (USA, Canada, Mexico)
%li%Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
%li%Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
%li%South America (Brazil, Argentina, Columbia, Rest of South America)
%li%The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
%li%Industry drivers, restraints, and opportunities covered in the study
%li%Neutral perspective on the market performance
%li%Recent industry trends and developments
%li%Competitive landscape & strategies of key players
%li%Potential & niche segments and regions exhibiting promising growth covered
%li%Historical, current, and projected market size, in terms of value
%li%In-depth analysis of the Human Tuberculosis Vaccine Market
%li%Overview of the regional outlook of the Human Tuberculosis Vaccine Market:
Key Reasons to Buy this Report:
%li%Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
%li%This enables you to anticipate market changes to remain ahead of your competitors
%li%You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
%li%The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
%li%Provision of market value (USD Billion) data for each segment and sub-segment
%li%Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
%li%Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
%li%Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
%li%Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
%li%The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
%li%Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
%li%Provides insight into the market through Value Chain
%li%Market dynamics scenario, along with growth opportunities of the market in the years to come
%li%6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Human Tuberculosis Vaccine Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
This report provides a deep insight into the global Human Tuberculosis Vaccine market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Human Tuberculosis Vaccine Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Human Tuberculosis Vaccine market in any manner.
Global Human Tuberculosis Vaccine Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
GlaxoSmithKline
Merck
Serum Institute of India
Valneva
Archivel Farma
BIOFABRI (Zendal)
Japan BCG Laboratory
GreenSignal Bio Pharma
AJ Vaccines
Taj Pharma India
Biomed Lublin
Market Segmentation (by Type)
Intradermal
Percutaneous
Market Segmentation (by Application)
Pediatrics
Adults
Geographic Segmentation
%li%North America (USA, Canada, Mexico)
%li%Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
%li%Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
%li%South America (Brazil, Argentina, Columbia, Rest of South America)
%li%The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
%li%Industry drivers, restraints, and opportunities covered in the study
%li%Neutral perspective on the market performance
%li%Recent industry trends and developments
%li%Competitive landscape & strategies of key players
%li%Potential & niche segments and regions exhibiting promising growth covered
%li%Historical, current, and projected market size, in terms of value
%li%In-depth analysis of the Human Tuberculosis Vaccine Market
%li%Overview of the regional outlook of the Human Tuberculosis Vaccine Market:
Key Reasons to Buy this Report:
%li%Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
%li%This enables you to anticipate market changes to remain ahead of your competitors
%li%You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
%li%The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
%li%Provision of market value (USD Billion) data for each segment and sub-segment
%li%Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
%li%Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
%li%Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
%li%Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
%li%The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
%li%Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
%li%Provides insight into the market through Value Chain
%li%Market dynamics scenario, along with growth opportunities of the market in the years to come
%li%6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Human Tuberculosis Vaccine Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Human Tuberculosis Vaccine
1.2 Key Market Segments
1.2.1 Human Tuberculosis Vaccine Segment by Type
1.2.2 Human Tuberculosis Vaccine Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 HUMAN TUBERCULOSIS VACCINE MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Human Tuberculosis Vaccine Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Human Tuberculosis Vaccine Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 HUMAN TUBERCULOSIS VACCINE MARKET COMPETITIVE LANDSCAPE
3.1 Global Human Tuberculosis Vaccine Sales by Manufacturers (2019-2024)
3.2 Global Human Tuberculosis Vaccine Revenue Market Share by Manufacturers (2019-2024)
3.3 Human Tuberculosis Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Human Tuberculosis Vaccine Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Human Tuberculosis Vaccine Sales Sites, Area Served, Product Type
3.6 Human Tuberculosis Vaccine Market Competitive Situation and Trends
3.6.1 Human Tuberculosis Vaccine Market Concentration Rate
3.6.2 Global 5 and 10 Largest Human Tuberculosis Vaccine Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 HUMAN TUBERCULOSIS VACCINE INDUSTRY CHAIN ANALYSIS
4.1 Human Tuberculosis Vaccine Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF HUMAN TUBERCULOSIS VACCINE MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 HUMAN TUBERCULOSIS VACCINE MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Human Tuberculosis Vaccine Sales Market Share by Type (2019-2024)
6.3 Global Human Tuberculosis Vaccine Market Size Market Share by Type (2019-2024)
6.4 Global Human Tuberculosis Vaccine Price by Type (2019-2024)
7 HUMAN TUBERCULOSIS VACCINE MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Human Tuberculosis Vaccine Market Sales by Application (2019-2024)
7.3 Global Human Tuberculosis Vaccine Market Size (M USD) by Application (2019-2024)
7.4 Global Human Tuberculosis Vaccine Sales Growth Rate by Application (2019-2024)
8 HUMAN TUBERCULOSIS VACCINE MARKET SEGMENTATION BY REGION
8.1 Global Human Tuberculosis Vaccine Sales by Region
8.1.1 Global Human Tuberculosis Vaccine Sales by Region
8.1.2 Global Human Tuberculosis Vaccine Sales Market Share by Region
8.2 North America
8.2.1 North America Human Tuberculosis Vaccine Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Human Tuberculosis Vaccine Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Human Tuberculosis Vaccine Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Human Tuberculosis Vaccine Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Human Tuberculosis Vaccine Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 GlaxoSmithKline
9.1.1 GlaxoSmithKline Human Tuberculosis Vaccine Basic Information
9.1.2 GlaxoSmithKline Human Tuberculosis Vaccine Product Overview
9.1.3 GlaxoSmithKline Human Tuberculosis Vaccine Product Market Performance
9.1.4 GlaxoSmithKline Business Overview
9.1.5 GlaxoSmithKline Human Tuberculosis Vaccine SWOT Analysis
9.1.6 GlaxoSmithKline Recent Developments
9.2 Merck
9.2.1 Merck Human Tuberculosis Vaccine Basic Information
9.2.2 Merck Human Tuberculosis Vaccine Product Overview
9.2.3 Merck Human Tuberculosis Vaccine Product Market Performance
9.2.4 Merck Business Overview
9.2.5 Merck Human Tuberculosis Vaccine SWOT Analysis
9.2.6 Merck Recent Developments
9.3 Serum Institute of India
9.3.1 Serum Institute of India Human Tuberculosis Vaccine Basic Information
9.3.2 Serum Institute of India Human Tuberculosis Vaccine Product Overview
9.3.3 Serum Institute of India Human Tuberculosis Vaccine Product Market Performance
9.3.4 Serum Institute of India Human Tuberculosis Vaccine SWOT Analysis
9.3.5 Serum Institute of India Business Overview
9.3.6 Serum Institute of India Recent Developments
9.4 Valneva
9.4.1 Valneva Human Tuberculosis Vaccine Basic Information
9.4.2 Valneva Human Tuberculosis Vaccine Product Overview
9.4.3 Valneva Human Tuberculosis Vaccine Product Market Performance
9.4.4 Valneva Business Overview
9.4.5 Valneva Recent Developments
9.5 Archivel Farma
9.5.1 Archivel Farma Human Tuberculosis Vaccine Basic Information
9.5.2 Archivel Farma Human Tuberculosis Vaccine Product Overview
9.5.3 Archivel Farma Human Tuberculosis Vaccine Product Market Performance
9.5.4 Archivel Farma Business Overview
9.5.5 Archivel Farma Recent Developments
9.6 BIOFABRI (Zendal)
9.6.1 BIOFABRI (Zendal) Human Tuberculosis Vaccine Basic Information
9.6.2 BIOFABRI (Zendal) Human Tuberculosis Vaccine Product Overview
9.6.3 BIOFABRI (Zendal) Human Tuberculosis Vaccine Product Market Performance
9.6.4 BIOFABRI (Zendal) Business Overview
9.6.5 BIOFABRI (Zendal) Recent Developments
9.7 Japan BCG Laboratory
9.7.1 Japan BCG Laboratory Human Tuberculosis Vaccine Basic Information
9.7.2 Japan BCG Laboratory Human Tuberculosis Vaccine Product Overview
9.7.3 Japan BCG Laboratory Human Tuberculosis Vaccine Product Market Performance
9.7.4 Japan BCG Laboratory Business Overview
9.7.5 Japan BCG Laboratory Recent Developments
9.8 GreenSignal Bio Pharma
9.8.1 GreenSignal Bio Pharma Human Tuberculosis Vaccine Basic Information
9.8.2 GreenSignal Bio Pharma Human Tuberculosis Vaccine Product Overview
9.8.3 GreenSignal Bio Pharma Human Tuberculosis Vaccine Product Market Performance
9.8.4 GreenSignal Bio Pharma Business Overview
9.8.5 GreenSignal Bio Pharma Recent Developments
9.9 AJ Vaccines
9.9.1 AJ Vaccines Human Tuberculosis Vaccine Basic Information
9.9.2 AJ Vaccines Human Tuberculosis Vaccine Product Overview
9.9.3 AJ Vaccines Human Tuberculosis Vaccine Product Market Performance
9.9.4 AJ Vaccines Business Overview
9.9.5 AJ Vaccines Recent Developments
9.10 Taj Pharma India
9.10.1 Taj Pharma India Human Tuberculosis Vaccine Basic Information
9.10.2 Taj Pharma India Human Tuberculosis Vaccine Product Overview
9.10.3 Taj Pharma India Human Tuberculosis Vaccine Product Market Performance
9.10.4 Taj Pharma India Business Overview
9.10.5 Taj Pharma India Recent Developments
9.11 Biomed Lublin
9.11.1 Biomed Lublin Human Tuberculosis Vaccine Basic Information
9.11.2 Biomed Lublin Human Tuberculosis Vaccine Product Overview
9.11.3 Biomed Lublin Human Tuberculosis Vaccine Product Market Performance
9.11.4 Biomed Lublin Business Overview
9.11.5 Biomed Lublin Recent Developments
10 HUMAN TUBERCULOSIS VACCINE MARKET FORECAST BY REGION
10.1 Global Human Tuberculosis Vaccine Market Size Forecast
10.2 Global Human Tuberculosis Vaccine Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Human Tuberculosis Vaccine Market Size Forecast by Country
10.2.3 Asia Pacific Human Tuberculosis Vaccine Market Size Forecast by Region
10.2.4 South America Human Tuberculosis Vaccine Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Human Tuberculosis Vaccine by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Human Tuberculosis Vaccine Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Human Tuberculosis Vaccine by Type (2025-2030)
11.1.2 Global Human Tuberculosis Vaccine Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Human Tuberculosis Vaccine by Type (2025-2030)
11.2 Global Human Tuberculosis Vaccine Market Forecast by Application (2025-2030)
11.2.1 Global Human Tuberculosis Vaccine Sales (Kilotons) Forecast by Application
11.2.2 Global Human Tuberculosis Vaccine Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Human Tuberculosis Vaccine
1.2 Key Market Segments
1.2.1 Human Tuberculosis Vaccine Segment by Type
1.2.2 Human Tuberculosis Vaccine Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 HUMAN TUBERCULOSIS VACCINE MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Human Tuberculosis Vaccine Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Human Tuberculosis Vaccine Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 HUMAN TUBERCULOSIS VACCINE MARKET COMPETITIVE LANDSCAPE
3.1 Global Human Tuberculosis Vaccine Sales by Manufacturers (2019-2024)
3.2 Global Human Tuberculosis Vaccine Revenue Market Share by Manufacturers (2019-2024)
3.3 Human Tuberculosis Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Human Tuberculosis Vaccine Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Human Tuberculosis Vaccine Sales Sites, Area Served, Product Type
3.6 Human Tuberculosis Vaccine Market Competitive Situation and Trends
3.6.1 Human Tuberculosis Vaccine Market Concentration Rate
3.6.2 Global 5 and 10 Largest Human Tuberculosis Vaccine Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 HUMAN TUBERCULOSIS VACCINE INDUSTRY CHAIN ANALYSIS
4.1 Human Tuberculosis Vaccine Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF HUMAN TUBERCULOSIS VACCINE MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 HUMAN TUBERCULOSIS VACCINE MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Human Tuberculosis Vaccine Sales Market Share by Type (2019-2024)
6.3 Global Human Tuberculosis Vaccine Market Size Market Share by Type (2019-2024)
6.4 Global Human Tuberculosis Vaccine Price by Type (2019-2024)
7 HUMAN TUBERCULOSIS VACCINE MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Human Tuberculosis Vaccine Market Sales by Application (2019-2024)
7.3 Global Human Tuberculosis Vaccine Market Size (M USD) by Application (2019-2024)
7.4 Global Human Tuberculosis Vaccine Sales Growth Rate by Application (2019-2024)
8 HUMAN TUBERCULOSIS VACCINE MARKET SEGMENTATION BY REGION
8.1 Global Human Tuberculosis Vaccine Sales by Region
8.1.1 Global Human Tuberculosis Vaccine Sales by Region
8.1.2 Global Human Tuberculosis Vaccine Sales Market Share by Region
8.2 North America
8.2.1 North America Human Tuberculosis Vaccine Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Human Tuberculosis Vaccine Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Human Tuberculosis Vaccine Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Human Tuberculosis Vaccine Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Human Tuberculosis Vaccine Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 GlaxoSmithKline
9.1.1 GlaxoSmithKline Human Tuberculosis Vaccine Basic Information
9.1.2 GlaxoSmithKline Human Tuberculosis Vaccine Product Overview
9.1.3 GlaxoSmithKline Human Tuberculosis Vaccine Product Market Performance
9.1.4 GlaxoSmithKline Business Overview
9.1.5 GlaxoSmithKline Human Tuberculosis Vaccine SWOT Analysis
9.1.6 GlaxoSmithKline Recent Developments
9.2 Merck
9.2.1 Merck Human Tuberculosis Vaccine Basic Information
9.2.2 Merck Human Tuberculosis Vaccine Product Overview
9.2.3 Merck Human Tuberculosis Vaccine Product Market Performance
9.2.4 Merck Business Overview
9.2.5 Merck Human Tuberculosis Vaccine SWOT Analysis
9.2.6 Merck Recent Developments
9.3 Serum Institute of India
9.3.1 Serum Institute of India Human Tuberculosis Vaccine Basic Information
9.3.2 Serum Institute of India Human Tuberculosis Vaccine Product Overview
9.3.3 Serum Institute of India Human Tuberculosis Vaccine Product Market Performance
9.3.4 Serum Institute of India Human Tuberculosis Vaccine SWOT Analysis
9.3.5 Serum Institute of India Business Overview
9.3.6 Serum Institute of India Recent Developments
9.4 Valneva
9.4.1 Valneva Human Tuberculosis Vaccine Basic Information
9.4.2 Valneva Human Tuberculosis Vaccine Product Overview
9.4.3 Valneva Human Tuberculosis Vaccine Product Market Performance
9.4.4 Valneva Business Overview
9.4.5 Valneva Recent Developments
9.5 Archivel Farma
9.5.1 Archivel Farma Human Tuberculosis Vaccine Basic Information
9.5.2 Archivel Farma Human Tuberculosis Vaccine Product Overview
9.5.3 Archivel Farma Human Tuberculosis Vaccine Product Market Performance
9.5.4 Archivel Farma Business Overview
9.5.5 Archivel Farma Recent Developments
9.6 BIOFABRI (Zendal)
9.6.1 BIOFABRI (Zendal) Human Tuberculosis Vaccine Basic Information
9.6.2 BIOFABRI (Zendal) Human Tuberculosis Vaccine Product Overview
9.6.3 BIOFABRI (Zendal) Human Tuberculosis Vaccine Product Market Performance
9.6.4 BIOFABRI (Zendal) Business Overview
9.6.5 BIOFABRI (Zendal) Recent Developments
9.7 Japan BCG Laboratory
9.7.1 Japan BCG Laboratory Human Tuberculosis Vaccine Basic Information
9.7.2 Japan BCG Laboratory Human Tuberculosis Vaccine Product Overview
9.7.3 Japan BCG Laboratory Human Tuberculosis Vaccine Product Market Performance
9.7.4 Japan BCG Laboratory Business Overview
9.7.5 Japan BCG Laboratory Recent Developments
9.8 GreenSignal Bio Pharma
9.8.1 GreenSignal Bio Pharma Human Tuberculosis Vaccine Basic Information
9.8.2 GreenSignal Bio Pharma Human Tuberculosis Vaccine Product Overview
9.8.3 GreenSignal Bio Pharma Human Tuberculosis Vaccine Product Market Performance
9.8.4 GreenSignal Bio Pharma Business Overview
9.8.5 GreenSignal Bio Pharma Recent Developments
9.9 AJ Vaccines
9.9.1 AJ Vaccines Human Tuberculosis Vaccine Basic Information
9.9.2 AJ Vaccines Human Tuberculosis Vaccine Product Overview
9.9.3 AJ Vaccines Human Tuberculosis Vaccine Product Market Performance
9.9.4 AJ Vaccines Business Overview
9.9.5 AJ Vaccines Recent Developments
9.10 Taj Pharma India
9.10.1 Taj Pharma India Human Tuberculosis Vaccine Basic Information
9.10.2 Taj Pharma India Human Tuberculosis Vaccine Product Overview
9.10.3 Taj Pharma India Human Tuberculosis Vaccine Product Market Performance
9.10.4 Taj Pharma India Business Overview
9.10.5 Taj Pharma India Recent Developments
9.11 Biomed Lublin
9.11.1 Biomed Lublin Human Tuberculosis Vaccine Basic Information
9.11.2 Biomed Lublin Human Tuberculosis Vaccine Product Overview
9.11.3 Biomed Lublin Human Tuberculosis Vaccine Product Market Performance
9.11.4 Biomed Lublin Business Overview
9.11.5 Biomed Lublin Recent Developments
10 HUMAN TUBERCULOSIS VACCINE MARKET FORECAST BY REGION
10.1 Global Human Tuberculosis Vaccine Market Size Forecast
10.2 Global Human Tuberculosis Vaccine Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Human Tuberculosis Vaccine Market Size Forecast by Country
10.2.3 Asia Pacific Human Tuberculosis Vaccine Market Size Forecast by Region
10.2.4 South America Human Tuberculosis Vaccine Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Human Tuberculosis Vaccine by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Human Tuberculosis Vaccine Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Human Tuberculosis Vaccine by Type (2025-2030)
11.1.2 Global Human Tuberculosis Vaccine Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Human Tuberculosis Vaccine by Type (2025-2030)
11.2 Global Human Tuberculosis Vaccine Market Forecast by Application (2025-2030)
11.2.1 Global Human Tuberculosis Vaccine Sales (Kilotons) Forecast by Application
11.2.2 Global Human Tuberculosis Vaccine Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Human Tuberculosis Vaccine Market Size Comparison by Region (M USD)
Table 5. Global Human Tuberculosis Vaccine Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Human Tuberculosis Vaccine Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Human Tuberculosis Vaccine Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Human Tuberculosis Vaccine Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Tuberculosis Vaccine as of 2022)
Table 10. Global Market Human Tuberculosis Vaccine Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Human Tuberculosis Vaccine Sales Sites and Area Served
Table 12. Manufacturers Human Tuberculosis Vaccine Product Type
Table 13. Global Human Tuberculosis Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Human Tuberculosis Vaccine
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Human Tuberculosis Vaccine Market Challenges
Table 22. Global Human Tuberculosis Vaccine Sales by Type (Kilotons)
Table 23. Global Human Tuberculosis Vaccine Market Size by Type (M USD)
Table 24. Global Human Tuberculosis Vaccine Sales (Kilotons) by Type (2019-2024)
Table 25. Global Human Tuberculosis Vaccine Sales Market Share by Type (2019-2024)
Table 26. Global Human Tuberculosis Vaccine Market Size (M USD) by Type (2019-2024)
Table 27. Global Human Tuberculosis Vaccine Market Size Share by Type (2019-2024)
Table 28. Global Human Tuberculosis Vaccine Price (USD/Ton) by Type (2019-2024)
Table 29. Global Human Tuberculosis Vaccine Sales (Kilotons) by Application
Table 30. Global Human Tuberculosis Vaccine Market Size by Application
Table 31. Global Human Tuberculosis Vaccine Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Human Tuberculosis Vaccine Sales Market Share by Application (2019-2024)
Table 33. Global Human Tuberculosis Vaccine Sales by Application (2019-2024) & (M USD)
Table 34. Global Human Tuberculosis Vaccine Market Share by Application (2019-2024)
Table 35. Global Human Tuberculosis Vaccine Sales Growth Rate by Application (2019-2024)
Table 36. Global Human Tuberculosis Vaccine Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Human Tuberculosis Vaccine Sales Market Share by Region (2019-2024)
Table 38. North America Human Tuberculosis Vaccine Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Human Tuberculosis Vaccine Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Human Tuberculosis Vaccine Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Human Tuberculosis Vaccine Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Human Tuberculosis Vaccine Sales by Region (2019-2024) & (Kilotons)
Table 43. GlaxoSmithKline Human Tuberculosis Vaccine Basic Information
Table 44. GlaxoSmithKline Human Tuberculosis Vaccine Product Overview
Table 45. GlaxoSmithKline Human Tuberculosis Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. GlaxoSmithKline Business Overview
Table 47. GlaxoSmithKline Human Tuberculosis Vaccine SWOT Analysis
Table 48. GlaxoSmithKline Recent Developments
Table 49. Merck Human Tuberculosis Vaccine Basic Information
Table 50. Merck Human Tuberculosis Vaccine Product Overview
Table 51. Merck Human Tuberculosis Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. Merck Business Overview
Table 53. Merck Human Tuberculosis Vaccine SWOT Analysis
Table 54. Merck Recent Developments
Table 55. Serum Institute of India Human Tuberculosis Vaccine Basic Information
Table 56. Serum Institute of India Human Tuberculosis Vaccine Product Overview
Table 57. Serum Institute of India Human Tuberculosis Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. Serum Institute of India Human Tuberculosis Vaccine SWOT Analysis
Table 59. Serum Institute of India Business Overview
Table 60. Serum Institute of India Recent Developments
Table 61. Valneva Human Tuberculosis Vaccine Basic Information
Table 62. Valneva Human Tuberculosis Vaccine Product Overview
Table 63. Valneva Human Tuberculosis Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. Valneva Business Overview
Table 65. Valneva Recent Developments
Table 66. Archivel Farma Human Tuberculosis Vaccine Basic Information
Table 67. Archivel Farma Human Tuberculosis Vaccine Product Overview
Table 68. Archivel Farma Human Tuberculosis Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. Archivel Farma Business Overview
Table 70. Archivel Farma Recent Developments
Table 71. BIOFABRI (Zendal) Human Tuberculosis Vaccine Basic Information
Table 72. BIOFABRI (Zendal) Human Tuberculosis Vaccine Product Overview
Table 73. BIOFABRI (Zendal) Human Tuberculosis Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 74. BIOFABRI (Zendal) Business Overview
Table 75. BIOFABRI (Zendal) Recent Developments
Table 76. Japan BCG Laboratory Human Tuberculosis Vaccine Basic Information
Table 77. Japan BCG Laboratory Human Tuberculosis Vaccine Product Overview
Table 78. Japan BCG Laboratory Human Tuberculosis Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 79. Japan BCG Laboratory Business Overview
Table 80. Japan BCG Laboratory Recent Developments
Table 81. GreenSignal Bio Pharma Human Tuberculosis Vaccine Basic Information
Table 82. GreenSignal Bio Pharma Human Tuberculosis Vaccine Product Overview
Table 83. GreenSignal Bio Pharma Human Tuberculosis Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 84. GreenSignal Bio Pharma Business Overview
Table 85. GreenSignal Bio Pharma Recent Developments
Table 86. AJ Vaccines Human Tuberculosis Vaccine Basic Information
Table 87. AJ Vaccines Human Tuberculosis Vaccine Product Overview
Table 88. AJ Vaccines Human Tuberculosis Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 89. AJ Vaccines Business Overview
Table 90. AJ Vaccines Recent Developments
Table 91. Taj Pharma India Human Tuberculosis Vaccine Basic Information
Table 92. Taj Pharma India Human Tuberculosis Vaccine Product Overview
Table 93. Taj Pharma India Human Tuberculosis Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 94. Taj Pharma India Business Overview
Table 95. Taj Pharma India Recent Developments
Table 96. Biomed Lublin Human Tuberculosis Vaccine Basic Information
Table 97. Biomed Lublin Human Tuberculosis Vaccine Product Overview
Table 98. Biomed Lublin Human Tuberculosis Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 99. Biomed Lublin Business Overview
Table 100. Biomed Lublin Recent Developments
Table 101. Global Human Tuberculosis Vaccine Sales Forecast by Region (2025-2030) & (Kilotons)
Table 102. Global Human Tuberculosis Vaccine Market Size Forecast by Region (2025-2030) & (M USD)
Table 103. North America Human Tuberculosis Vaccine Sales Forecast by Country (2025-2030) & (Kilotons)
Table 104. North America Human Tuberculosis Vaccine Market Size Forecast by Country (2025-2030) & (M USD)
Table 105. Europe Human Tuberculosis Vaccine Sales Forecast by Country (2025-2030) & (Kilotons)
Table 106. Europe Human Tuberculosis Vaccine Market Size Forecast by Country (2025-2030) & (M USD)
Table 107. Asia Pacific Human Tuberculosis Vaccine Sales Forecast by Region (2025-2030) & (Kilotons)
Table 108. Asia Pacific Human Tuberculosis Vaccine Market Size Forecast by Region (2025-2030) & (M USD)
Table 109. South America Human Tuberculosis Vaccine Sales Forecast by Country (2025-2030) & (Kilotons)
Table 110. South America Human Tuberculosis Vaccine Market Size Forecast by Country (2025-2030) & (M USD)
Table 111. Middle East and Africa Human Tuberculosis Vaccine Consumption Forecast by Country (2025-2030) & (Units)
Table 112. Middle East and Africa Human Tuberculosis Vaccine Market Size Forecast by Country (2025-2030) & (M USD)
Table 113. Global Human Tuberculosis Vaccine Sales Forecast by Type (2025-2030) & (Kilotons)
Table 114. Global Human Tuberculosis Vaccine Market Size Forecast by Type (2025-2030) & (M USD)
Table 115. Global Human Tuberculosis Vaccine Price Forecast by Type (2025-2030) & (USD/Ton)
Table 116. Global Human Tuberculosis Vaccine Sales (Kilotons) Forecast by Application (2025-2030)
Table 117. Global Human Tuberculosis Vaccine Market Size Forecast by Application (2025-2030) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Human Tuberculosis Vaccine Market Size Comparison by Region (M USD)
Table 5. Global Human Tuberculosis Vaccine Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Human Tuberculosis Vaccine Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Human Tuberculosis Vaccine Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Human Tuberculosis Vaccine Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Tuberculosis Vaccine as of 2022)
Table 10. Global Market Human Tuberculosis Vaccine Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Human Tuberculosis Vaccine Sales Sites and Area Served
Table 12. Manufacturers Human Tuberculosis Vaccine Product Type
Table 13. Global Human Tuberculosis Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Human Tuberculosis Vaccine
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Human Tuberculosis Vaccine Market Challenges
Table 22. Global Human Tuberculosis Vaccine Sales by Type (Kilotons)
Table 23. Global Human Tuberculosis Vaccine Market Size by Type (M USD)
Table 24. Global Human Tuberculosis Vaccine Sales (Kilotons) by Type (2019-2024)
Table 25. Global Human Tuberculosis Vaccine Sales Market Share by Type (2019-2024)
Table 26. Global Human Tuberculosis Vaccine Market Size (M USD) by Type (2019-2024)
Table 27. Global Human Tuberculosis Vaccine Market Size Share by Type (2019-2024)
Table 28. Global Human Tuberculosis Vaccine Price (USD/Ton) by Type (2019-2024)
Table 29. Global Human Tuberculosis Vaccine Sales (Kilotons) by Application
Table 30. Global Human Tuberculosis Vaccine Market Size by Application
Table 31. Global Human Tuberculosis Vaccine Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Human Tuberculosis Vaccine Sales Market Share by Application (2019-2024)
Table 33. Global Human Tuberculosis Vaccine Sales by Application (2019-2024) & (M USD)
Table 34. Global Human Tuberculosis Vaccine Market Share by Application (2019-2024)
Table 35. Global Human Tuberculosis Vaccine Sales Growth Rate by Application (2019-2024)
Table 36. Global Human Tuberculosis Vaccine Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Human Tuberculosis Vaccine Sales Market Share by Region (2019-2024)
Table 38. North America Human Tuberculosis Vaccine Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Human Tuberculosis Vaccine Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Human Tuberculosis Vaccine Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Human Tuberculosis Vaccine Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Human Tuberculosis Vaccine Sales by Region (2019-2024) & (Kilotons)
Table 43. GlaxoSmithKline Human Tuberculosis Vaccine Basic Information
Table 44. GlaxoSmithKline Human Tuberculosis Vaccine Product Overview
Table 45. GlaxoSmithKline Human Tuberculosis Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. GlaxoSmithKline Business Overview
Table 47. GlaxoSmithKline Human Tuberculosis Vaccine SWOT Analysis
Table 48. GlaxoSmithKline Recent Developments
Table 49. Merck Human Tuberculosis Vaccine Basic Information
Table 50. Merck Human Tuberculosis Vaccine Product Overview
Table 51. Merck Human Tuberculosis Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. Merck Business Overview
Table 53. Merck Human Tuberculosis Vaccine SWOT Analysis
Table 54. Merck Recent Developments
Table 55. Serum Institute of India Human Tuberculosis Vaccine Basic Information
Table 56. Serum Institute of India Human Tuberculosis Vaccine Product Overview
Table 57. Serum Institute of India Human Tuberculosis Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. Serum Institute of India Human Tuberculosis Vaccine SWOT Analysis
Table 59. Serum Institute of India Business Overview
Table 60. Serum Institute of India Recent Developments
Table 61. Valneva Human Tuberculosis Vaccine Basic Information
Table 62. Valneva Human Tuberculosis Vaccine Product Overview
Table 63. Valneva Human Tuberculosis Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. Valneva Business Overview
Table 65. Valneva Recent Developments
Table 66. Archivel Farma Human Tuberculosis Vaccine Basic Information
Table 67. Archivel Farma Human Tuberculosis Vaccine Product Overview
Table 68. Archivel Farma Human Tuberculosis Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. Archivel Farma Business Overview
Table 70. Archivel Farma Recent Developments
Table 71. BIOFABRI (Zendal) Human Tuberculosis Vaccine Basic Information
Table 72. BIOFABRI (Zendal) Human Tuberculosis Vaccine Product Overview
Table 73. BIOFABRI (Zendal) Human Tuberculosis Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 74. BIOFABRI (Zendal) Business Overview
Table 75. BIOFABRI (Zendal) Recent Developments
Table 76. Japan BCG Laboratory Human Tuberculosis Vaccine Basic Information
Table 77. Japan BCG Laboratory Human Tuberculosis Vaccine Product Overview
Table 78. Japan BCG Laboratory Human Tuberculosis Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 79. Japan BCG Laboratory Business Overview
Table 80. Japan BCG Laboratory Recent Developments
Table 81. GreenSignal Bio Pharma Human Tuberculosis Vaccine Basic Information
Table 82. GreenSignal Bio Pharma Human Tuberculosis Vaccine Product Overview
Table 83. GreenSignal Bio Pharma Human Tuberculosis Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 84. GreenSignal Bio Pharma Business Overview
Table 85. GreenSignal Bio Pharma Recent Developments
Table 86. AJ Vaccines Human Tuberculosis Vaccine Basic Information
Table 87. AJ Vaccines Human Tuberculosis Vaccine Product Overview
Table 88. AJ Vaccines Human Tuberculosis Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 89. AJ Vaccines Business Overview
Table 90. AJ Vaccines Recent Developments
Table 91. Taj Pharma India Human Tuberculosis Vaccine Basic Information
Table 92. Taj Pharma India Human Tuberculosis Vaccine Product Overview
Table 93. Taj Pharma India Human Tuberculosis Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 94. Taj Pharma India Business Overview
Table 95. Taj Pharma India Recent Developments
Table 96. Biomed Lublin Human Tuberculosis Vaccine Basic Information
Table 97. Biomed Lublin Human Tuberculosis Vaccine Product Overview
Table 98. Biomed Lublin Human Tuberculosis Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 99. Biomed Lublin Business Overview
Table 100. Biomed Lublin Recent Developments
Table 101. Global Human Tuberculosis Vaccine Sales Forecast by Region (2025-2030) & (Kilotons)
Table 102. Global Human Tuberculosis Vaccine Market Size Forecast by Region (2025-2030) & (M USD)
Table 103. North America Human Tuberculosis Vaccine Sales Forecast by Country (2025-2030) & (Kilotons)
Table 104. North America Human Tuberculosis Vaccine Market Size Forecast by Country (2025-2030) & (M USD)
Table 105. Europe Human Tuberculosis Vaccine Sales Forecast by Country (2025-2030) & (Kilotons)
Table 106. Europe Human Tuberculosis Vaccine Market Size Forecast by Country (2025-2030) & (M USD)
Table 107. Asia Pacific Human Tuberculosis Vaccine Sales Forecast by Region (2025-2030) & (Kilotons)
Table 108. Asia Pacific Human Tuberculosis Vaccine Market Size Forecast by Region (2025-2030) & (M USD)
Table 109. South America Human Tuberculosis Vaccine Sales Forecast by Country (2025-2030) & (Kilotons)
Table 110. South America Human Tuberculosis Vaccine Market Size Forecast by Country (2025-2030) & (M USD)
Table 111. Middle East and Africa Human Tuberculosis Vaccine Consumption Forecast by Country (2025-2030) & (Units)
Table 112. Middle East and Africa Human Tuberculosis Vaccine Market Size Forecast by Country (2025-2030) & (M USD)
Table 113. Global Human Tuberculosis Vaccine Sales Forecast by Type (2025-2030) & (Kilotons)
Table 114. Global Human Tuberculosis Vaccine Market Size Forecast by Type (2025-2030) & (M USD)
Table 115. Global Human Tuberculosis Vaccine Price Forecast by Type (2025-2030) & (USD/Ton)
Table 116. Global Human Tuberculosis Vaccine Sales (Kilotons) Forecast by Application (2025-2030)
Table 117. Global Human Tuberculosis Vaccine Market Size Forecast by Application (2025-2030) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Human Tuberculosis Vaccine
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Human Tuberculosis Vaccine Market Size (M USD), 2019-2030
Figure 5. Global Human Tuberculosis Vaccine Market Size (M USD) (2019-2030)
Figure 6. Global Human Tuberculosis Vaccine Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Human Tuberculosis Vaccine Market Size by Country (M USD)
Figure 11. Human Tuberculosis Vaccine Sales Share by Manufacturers in 2023
Figure 12. Global Human Tuberculosis Vaccine Revenue Share by Manufacturers in 2023
Figure 13. Human Tuberculosis Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Human Tuberculosis Vaccine Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Human Tuberculosis Vaccine Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Human Tuberculosis Vaccine Market Share by Type
Figure 18. Sales Market Share of Human Tuberculosis Vaccine by Type (2019-2024)
Figure 19. Sales Market Share of Human Tuberculosis Vaccine by Type in 2023
Figure 20. Market Size Share of Human Tuberculosis Vaccine by Type (2019-2024)
Figure 21. Market Size Market Share of Human Tuberculosis Vaccine by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Human Tuberculosis Vaccine Market Share by Application
Figure 24. Global Human Tuberculosis Vaccine Sales Market Share by Application (2019-2024)
Figure 25. Global Human Tuberculosis Vaccine Sales Market Share by Application in 2023
Figure 26. Global Human Tuberculosis Vaccine Market Share by Application (2019-2024)
Figure 27. Global Human Tuberculosis Vaccine Market Share by Application in 2023
Figure 28. Global Human Tuberculosis Vaccine Sales Growth Rate by Application (2019-2024)
Figure 29. Global Human Tuberculosis Vaccine Sales Market Share by Region (2019-2024)
Figure 30. North America Human Tuberculosis Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Human Tuberculosis Vaccine Sales Market Share by Country in 2023
Figure 32. U.S. Human Tuberculosis Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Human Tuberculosis Vaccine Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Human Tuberculosis Vaccine Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Human Tuberculosis Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Human Tuberculosis Vaccine Sales Market Share by Country in 2023
Figure 37. Germany Human Tuberculosis Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Human Tuberculosis Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Human Tuberculosis Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Human Tuberculosis Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Human Tuberculosis Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Human Tuberculosis Vaccine Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Human Tuberculosis Vaccine Sales Market Share by Region in 2023
Figure 44. China Human Tuberculosis Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Human Tuberculosis Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Human Tuberculosis Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Human Tuberculosis Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Human Tuberculosis Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Human Tuberculosis Vaccine Sales and Growth Rate (Kilotons)
Figure 50. South America Human Tuberculosis Vaccine Sales Market Share by Country in 2023
Figure 51. Brazil Human Tuberculosis Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Human Tuberculosis Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Human Tuberculosis Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Human Tuberculosis Vaccine Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Human Tuberculosis Vaccine Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Human Tuberculosis Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Human Tuberculosis Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Human Tuberculosis Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Human Tuberculosis Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Human Tuberculosis Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Human Tuberculosis Vaccine Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Human Tuberculosis Vaccine Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Human Tuberculosis Vaccine Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Human Tuberculosis Vaccine Market Share Forecast by Type (2025-2030)
Figure 65. Global Human Tuberculosis Vaccine Sales Forecast by Application (2025-2030)
Figure 66. Global Human Tuberculosis Vaccine Market Share Forecast by Application (2025-2030)
Figure 1. Product Picture of Human Tuberculosis Vaccine
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Human Tuberculosis Vaccine Market Size (M USD), 2019-2030
Figure 5. Global Human Tuberculosis Vaccine Market Size (M USD) (2019-2030)
Figure 6. Global Human Tuberculosis Vaccine Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Human Tuberculosis Vaccine Market Size by Country (M USD)
Figure 11. Human Tuberculosis Vaccine Sales Share by Manufacturers in 2023
Figure 12. Global Human Tuberculosis Vaccine Revenue Share by Manufacturers in 2023
Figure 13. Human Tuberculosis Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Human Tuberculosis Vaccine Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Human Tuberculosis Vaccine Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Human Tuberculosis Vaccine Market Share by Type
Figure 18. Sales Market Share of Human Tuberculosis Vaccine by Type (2019-2024)
Figure 19. Sales Market Share of Human Tuberculosis Vaccine by Type in 2023
Figure 20. Market Size Share of Human Tuberculosis Vaccine by Type (2019-2024)
Figure 21. Market Size Market Share of Human Tuberculosis Vaccine by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Human Tuberculosis Vaccine Market Share by Application
Figure 24. Global Human Tuberculosis Vaccine Sales Market Share by Application (2019-2024)
Figure 25. Global Human Tuberculosis Vaccine Sales Market Share by Application in 2023
Figure 26. Global Human Tuberculosis Vaccine Market Share by Application (2019-2024)
Figure 27. Global Human Tuberculosis Vaccine Market Share by Application in 2023
Figure 28. Global Human Tuberculosis Vaccine Sales Growth Rate by Application (2019-2024)
Figure 29. Global Human Tuberculosis Vaccine Sales Market Share by Region (2019-2024)
Figure 30. North America Human Tuberculosis Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Human Tuberculosis Vaccine Sales Market Share by Country in 2023
Figure 32. U.S. Human Tuberculosis Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Human Tuberculosis Vaccine Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Human Tuberculosis Vaccine Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Human Tuberculosis Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Human Tuberculosis Vaccine Sales Market Share by Country in 2023
Figure 37. Germany Human Tuberculosis Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Human Tuberculosis Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Human Tuberculosis Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Human Tuberculosis Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Human Tuberculosis Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Human Tuberculosis Vaccine Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Human Tuberculosis Vaccine Sales Market Share by Region in 2023
Figure 44. China Human Tuberculosis Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Human Tuberculosis Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Human Tuberculosis Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Human Tuberculosis Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Human Tuberculosis Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Human Tuberculosis Vaccine Sales and Growth Rate (Kilotons)
Figure 50. South America Human Tuberculosis Vaccine Sales Market Share by Country in 2023
Figure 51. Brazil Human Tuberculosis Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Human Tuberculosis Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Human Tuberculosis Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Human Tuberculosis Vaccine Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Human Tuberculosis Vaccine Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Human Tuberculosis Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Human Tuberculosis Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Human Tuberculosis Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Human Tuberculosis Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Human Tuberculosis Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Human Tuberculosis Vaccine Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Human Tuberculosis Vaccine Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Human Tuberculosis Vaccine Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Human Tuberculosis Vaccine Market Share Forecast by Type (2025-2030)
Figure 65. Global Human Tuberculosis Vaccine Sales Forecast by Application (2025-2030)
Figure 66. Global Human Tuberculosis Vaccine Market Share Forecast by Application (2025-2030)
